联系我们,

开始

联系销售
alcatraz-press-release-hero-1x

模型N获取Deloitte的生命科学定价和承包解决方案业务188金宝搏备用网址

2020年12月17日,

188金宝搏体育收益管理市场领导者通过收购扩大市场机会

加州圣马特奥市。- Dec 17,2020 - Model N,Inc。(纽约证券交易所代码:Modn),云收入管理解决方案的领导者,今天宣188金宝搏体育布已纳入最终协议,以获得Deloitte的生命科学定价和承包解决方案业务和潜在技术。188金宝搏备用网址

此次收购扩大了Model N的投资组合,以更好地服务于从商业化前到世界上最大的生命科学公司的更大的市场份额。188金宝搏备用网址它还带来了新的生命科学客户、人才和知识188金宝搏备用网址产权,以补充Model N强大的客户基础和市场领先产品。

“我们非常兴奋地欢迎Deloitte的生命科学定价和承包解决方案客户和员工到型号社区。188金宝搏备用网址We believe the acquisition of this business allows us to offer revenue management to the broader life sciences market” said Jason Blessing, president and chief executive officer of Model N. “Deloitte’s cloud software and expert services solution are purpose built to help companies scale from pre-commercial to billion dollar enterprises. Model N has not historically gone after the pre-commercial segment so this is an exciting addition to our total addressable market.”

Model N计划以6000万美元现金收购德勤的生命科学定价和合同解决方188金宝搏备用网址案业务以及基础技术。Model N预计该交易将于2020年12月底完成,不会对其2021财年第一季度业绩产生任何影响。该交易的更多财务细节将在交易结束后的Model N 2021财年第一季度收益电话会议上提供。

模型N

模型N使生命科学和高科技公司能够188金宝搏备用网址推动增长和市场份额,最大限度地减少整个收入生命周期的收入泄漏。凭借深厚的行业专业知识和专门为这些行业打造的解决方案,Model N提供了全面的可视性、洞察力和对商业运营和合规的复杂性的控制。它的集成云解决方案已被证明可以自动定价、激励和合同决策,从而扩大业务利润和增加收入。Model N在超过120个国家受到世界领先的制药、医疗技术、半导体和高科技公司的信任,包括强生、阿斯利康、史赛克、希捷科技、博通和微芯片技术。欲了解更多信息,请访问www.tvnrw.com

如本文件所使用的,“Deloitte”意味着Deloitte LLP的子公司Deloitte&Touche LLP。请参阅www.deloitte.com/us/about有关其法律结构的详细说明。根据公共会计的规则和规定,某些服务可能无法为客户提供证明。

前瞻性陈述

此新闻稿包含前瞻性陈述,其中包括关于模型N的产品组合和价值主张的陈述。“相信”的词语“可以,”“\”“估计”,“继续,”“预期”,“打算”,“”期望“,”期望“和类似的表达式旨在识别前瞻性陈述。这些前瞻性陈述受风险,不确定性和假设的影响。如果风险实现或假设证明不正确,实际结果可能会因这些前瞻性陈述所暗示的结果而异。风险包括,但不限于:(i)交易不会在预期的时间表中完成的可能性,或者根本不会满足完成交易所需的条件;(ii)与我们收购相关的预期效益可能不会按预期实现的可能性;(iii)能够成功地整合Deloitte的生命科学定价和承包解决方案的业务和潜在技术;188金宝搏备用网址(iv)结束客户合同的延误;(v)我们改善和维持销售执行的能力;(vi)新订单及相关收入承认的时间; (vii) adverse changes in general economic or market conditions; (viii) delays or reductions in information technology spending and resulting variability in customer orders from quarter to quarter; (ix) competitive factors, including but not limited to pricing pressures, industry consolidation, entry of new competitors and new applications and marketing initiatives by our competitors; (x) our ability to manage our growth effectively; (xi) acceptance of our applications and services by customers; (xii) success of new products; (xiii) the risk that the strategic initiatives that we may pursue will not result in significant future revenues; (xiv) changes in health care regulation and policy and tax in the United States and worldwide; (xv) our ability to retain customers; and (xxi) adverse impacts on our business and financial condition due to COVID-19. Further information on risks that could affect Model N’s results is included in our filings with the Securities and Exchange Commission (“SEC”), including our most recent quarterly report on Form 10-Q and our annual report on Form 10-K for the fiscal year ended September 30, 2020, and any current reports on Form 8-K that we may file from time to time. Should any of these risks or uncertainties materialize, actual results could differ materially from expectations. Model N assumes no obligation to, and does not currently intend to, update any such forward-looking statements after the date of this release.

如需更多资料,请联络:
Beth Pampaloni.
公司传讯高级总监
N模型
bpampaloni@modeln.com.
(650) 867 - 9875

格温到来
导演,投资者关系
N模型
investorrelations@modeln.com
(650) 610 - 4998

开始输入并按回车键进行搜索

当我们共同努力时,我们会走得更远 近距离